文献速递儿童神经与发育行为

注意缺陷多动障碍儿童用药持续性的预测因素

Predictors of Medication Continuity in Children With ADHD.
PubMed 文献 · Pediatrics · 2018-01-01

研究纳入89名6至10岁新接受注意缺陷多动障碍(ADHD)药物治疗的儿童,由11家诊所的44名儿科医生诊治,前瞻性追踪用药持续性。结果显示,开始用药后0至90天用药覆盖天数中位数为81%,91至450天为54%;短期持续性与用药信息满意度、剂量调整、症状改善及家长信念等相关,长期持续性则与3个月时儿童对治疗的接受度及家长对用药需求与担忧的差值相关。

要点

  • ADHD儿童用药覆盖天数中位数从短期81%降至长期54%。
  • 短期用药持续性关联用药信息满意度、剂量调整、症状改善及家长信念。
  • 长期持续性关联3个月时儿童治疗接受度及家长需求与担忧差值。

核心结论

  • 用药持续性是一个随时间变化的过程,可随治疗体验而改变。

研究设计与样本

  • 前瞻性纵向队列研究,纳入89名6至10岁新接受ADHD药物治疗的儿童,由11家诊所的44名儿科医生诊治。

主要发现

  • 开始用药后0至90天用药覆盖天数中位数为81%,91至450天为54%。
  • 短期(0至90天)用药覆盖与儿童年龄、用药信息满意度、药物剂量调整、症状减轻、家长对症状控制的信念、对药物治疗的不确定性及工作联盟相关。
  • 长期(91至450天)用药持续性与3个月时儿童对治疗的接受度及家长对用药需求与担忧的差值相关,而非基线因素。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To identify predictors of attention-deficit/hyperactivity disorder (ADHD) medication continuity, hypothesizing greater continuity among children with (1) greater child acceptance of treatment, (2) parent belief in longer time course for ADHD, (3) positive differential between parent-perceived need for and concerns about medication, and (4) greater parent-perceived alliance with their child's doctor. METHODS: We conducted a prospective longitudinal cohort of 89 children aged 6 to 10 years old newly treated for ADHD by 1 of 44 pediatricians in 11 practices. Parents completed validated surveys on their beliefs about ADHD and medicine. We audited charts and obtained pharmacy dispensing records. In our analyses, we examined the relationship between predictor variables (eg, sociodemographic and clinical characteristics, quality of care, and belief measures) and short-term (first 90 days after starting medication) and long-term (91-450 days) medication continuity as defined by the number of days covered with medication. RESULTS: Children had a median of 81% of days covered over 0 to 90 days and 54% of days covered over 91 to 450 days after starting medicine. In the first 90 days, medication coverage related to child age, satisfaction with information about medicine, medication titration, symptom reduction, parent beliefs about control over symptoms, uncertainty about treating with medicine, and working alliance. Long-term medication continuity related to child acceptance of treatment and differential between parent-perceived need for and concerns about medication at 3 months, not baseline factors. CONCLUSIONS: Adherence is a process that can change over time in response to experiences with treatment. Interventions are needed to promote productive interactions between pediatricians and families in support of continuity.

来源:Pediatrics,查看原文。版权归原作者所有。

引用

  1. Brinkman WB, Sucharew H, Majcher JH, et al. Predictors of Medication Continuity in Children With ADHD. Pediatrics. 2018. PMID: 29794230. doi:10.1542/peds.2017-2580

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。